September « 2013 « Science and Enterprise

Investment Fund to Finance Global Health Technologies

By Alan, on September 23rd, 2013%

Girls at a malaria prevention event in Ghana (USAID.gov)

A consortium of private sector, foundation, and government partners formed the Global Health Investment Fund, to finance higher-risk, late-stage development of vaccines and other public health innovations in low-income countries. The fund is led by the bank JPMorgan Chase and the Bill & Melinda . . . → Read More: Investment Fund to Finance Global Health Technologies

Challenge Seeks Commercialization of Breast Cancer Advances

By Alan, on September 20th, 2013%

(National Cancer Institute)

A new challenge sponsored by the Avon Foundation for Women, with National Cancer Institute and Center for Advancing Innovation, aims to accelerate commercialization of unlicensed research discoveries related to breast cancer. In the Breast Cancer Start-up Challenge, Avon Foundation will award $250,000 to teams starting new companies that combine lab discoveries . . . → Read More: Challenge Seeks Commercialization of Breast Cancer Advances

Biotech Financing Up, Licensing Down in First Half of 2013

By Alan, on September 19th, 2013%

The biotechnology industry experienced healthy growth in venture financing and valuations in the first half of 2013, but licensing deals — a prime source of biotech revenue — were flat during the period, pointing to limits on the industry’s growth potential. This accounting of biotech industry financial activity is described in a report from Evaluate . . . → Read More: Biotech Financing Up, Licensing Down in First Half of 2013

NIST Funding $7.4M for Additive Manufacturing Standards

By Alan, on September 19th, 2013%

Additive processes test measurements (NIST.gov)

National Institute of Standards and Technology (NIST), an agency of U.S. Department of Commerce, is awarding two grants totaling $7.4 million to improve measurement and standards for additive manufacturing, industrial applications of three-dimensional printing. Most of the money — $5 million — is going to a consortium of 27 . . . → Read More: NIST Funding $7.4M for Additive Manufacturing Standards

Biotech Start-Up Finds STD Treatment in Anti-Cancer Therapy

By Alan, on September 18th, 2013%

Electron micrograph of Neisseria gonorrhoeae (NIH.gov)

Researchers with the biotechnology company TherapyX Inc. in Buffalo, New York found a potential treatment for the sexually transmitted disease (STD) gonorrhea in a therapy the company is developing for cancer. The team from TherapyX, a spin-off company of the University at Buffalo medical school, published its . . . → Read More: Biotech Start-Up Finds STD Treatment in Anti-Cancer Therapy

Cleveland Clinic Spin-Off Developing Breast Cancer Vaccine

By Alan, on September 18th, 2013%

Vincent Tuohy (Cleveland Clinic)

Shield Biotech, a spin-off company from the Cleveland Clinic in Ohio, is creating a vaccine to prevent breast cancer based on research conducted at the clinic’s research institute. Vincent Tuohy, a Cleveland Clinic immunologist, founded the company with the clinic’s commercialization division, and serves as its chief scientist.

Tuohy’s research . . . → Read More: Cleveland Clinic Spin-Off Developing Breast Cancer Vaccine

Graphene Photodetector Integrated with Semiconductor Chip

By Alan, on September 17th, 2013%

Thomas Mueller (H. Lackinger, Vienna University of Technology)

Researchers at Vienna University of Technology and Johannes Kepler University in Linz, Austria built a detector and converter of optical signals with graphene into a traditional semiconductor chip, making it easier to integrate optics and electronics in a single device. The team led by Vienna’s . . . → Read More: Graphene Photodetector Integrated with Semiconductor Chip

Lab-On-Chip Diagnostics Company Lands $2.1M Angel Financing

By Alan, on September 16th, 2013%

Prototype cell analyzer (ChipCare Corp.)

ChipCare Corp., a spin-off company from University of Toronto in Canada developing hand-held diagnostics devices to replace fixed expensive lab equipment, secured $2.05 million in early stage angel financing. The deal combines investments from university, private-sector, and Canadian government sources, according to an announcement by Grand Challenges Canada, . . . → Read More: Lab-On-Chip Diagnostics Company Lands $2.1M Angel Financing

Engineered Castor Beans Growth-Tested as Biofuel Feedstock

By Alan, on September 16th, 2013%

Castor beans (plants.usda.gov)

The plant genomics company Evogene Ltd. in Rehovot, Israel says growing trials of its engineered castor bean show it is ready for commercial development as an alternative feedstock for biodiesel fuels and other industrial products. The three-year trials were conducted in Brazil with SLC Agrícola S.A., a grower of soybeans, corn, . . . → Read More: Engineered Castor Beans Growth-Tested as Biofuel Feedstock

Fox Foundation, Companies Create Research Tools Group

By Alan, on September 13th, 2013%

(National Institute of Drug Abuse)

The Michael J. Fox Foundation for Parkinson’s Research in New York and seven companies are joining in a consortium to systematize development and sharing of tools for studying Parkinson’s disease. The seven companies are Amicus Therapeutics, ApoPharma, Biogen Idec, Eli Lilly and Company, Pfizer, PsychoGenics and Upsher-Smith Laboratories.

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise